Hydrogel helps to regenerate cartilage


Monday, 15 July, 2019

Hydrogel helps to regenerate cartilage

An international team of scientists has shown that polyacrylate hydrogels create the support and microenvironment necessary for the growth and maintenance of cartilage cells (chondrocytes), and could be optimal candidates for use in clinical practice. Their work has been published in the journal Acta Biomaterialia.

Cartilage degeneration and damage treatment remain a major challenge in today’s society; hence, tissue engineering strategies are being developed to investigate new alternatives based on a combination of cell therapy and 3D scaffolds to support cartilage cells. Now, a research team led by Spain’s University of Granada (UGR) has designed a new hydrogel using pioneering ‘polymer microarrays’ technology, which successfully helps to regenerate cartilage.

The researchers evaluated the adhesion capacity and viability of healthy chondrocytes extracted from patients with osteoarthritis of the knee, screening over 380 different polyacrylate and polyurethane polymers. Of these 380 alternatives, they selected the 10 polymers that presented the best properties in terms of facilitating the adhesion and viability of this cell type in particular. They also performed further assays to test the ability of these 10 polymers to support chondrocyte proliferation to produce cartilage matrix in long-term cultures.

The polymer poly (methylmethacrylate-co-methacrylic acid) was found to present the best biological and chemical characteristics, and was thus selected to synthesise hydrogels for use as 3D matrices. The analysis and characterisation of the ultra-structural morphology, the microstructure and the mechanical tests of this new hydrogel showed that it possessed the required characteristics to generate a support that mimics the environment that chondrocytes need in the cartilage.

Furthermore, biological characterisation of this material showed that it has the capacity to generate the appropriate niche for growth in a number of chondrocytes, while retaining their characteristics in the long-term culture in the laboratory setting. This was demonstrated by the high expression of genes characteristic of chondrogenesis, such as Type II collagen, SOX-9 and aggrecan. These chondrocytes proliferated by colonising the entire hydrogel, producing an extracellular matrix rich in proteoglycans similar to that which they produce in native cartilage.

Subsequent studies on mice verified the tremendous potential of this polyacrylate. First, the implantation of the hydrogel in immunocompetent mice showed that the material is totally biocompatible, presenting no signs of rejection by the organism. Furthermore, mouse cells colonised the hydrogel and secreted extracellular matrix. Second, the implantation of the hydrogel after it had previously been in culture with patients’ chondrocytes for 21 days showed that, when taken from the mice, the chondrocytes continued maintaining their viability, proliferating and expressing chondrogenesis genes, producing the matrix typical of the aforementioned cartilage.

“It is for this reason that the poly hydrogel (methylmethacrylate-co-methacrylic acid) presents structural characteristics and mechanical and biological properties that help generate a substitute tissue similar to healthy cartilage,” said Professor Juan Antonio Marchal Corrales, principal author of the paper. “We therefore propose this new material as an excellent candidate for cartilage regeneration, to overcome the limitations of current approaches based on scaffolding in the treatment of osteoarthritis.”

Image credit: ©stock.adobe.com/au/tonaquatic

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...

Plug-and-play test evaluates T cell immunotherapy effectiveness

The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...

Common heart medicine may be causing depression

Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd